Alaunos Therapeutics, Inc.
TCRT
$2.08
$0.010.48%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 354.00K | 1.39M | 1.94M | 2.88M | 319.00K |
| Total Receivables | -- | 3.00K | -- | 2.00K | 2.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 228.00K | 378.00K | -- | 857.00K | 746.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 388.00K | 222.00K | 747.00K | -- | -- |
| Total Current Assets | 970.00K | 1.99M | 2.69M | 3.74M | 1.07M |
|
|
|||||
| Total Current Assets | 970.00K | 1.99M | 2.69M | 3.74M | 1.07M |
| Net Property, Plant & Equipment | 82.00K | 91.00K | 97.00K | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 831.00K | 887.00K | 942.00K | 997.00K | 1.05M |
| Total Assets | 1.88M | 2.97M | 3.72M | 4.74M | 2.12M |
|
|
|||||
| Total Accounts Payable | 400.00K | 613.00K | 843.00K | 809.00K | 831.00K |
| Total Accrued Expenses | 195.00K | 200.00K | 78.00K | 265.00K | 231.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 595.00K | 813.00K | 921.00K | 1.07M | 1.06M |
|
|
|||||
| Total Current Liabilities | 595.00K | 813.00K | 921.00K | 1.07M | 1.06M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 595.00K | 813.00K | 921.00K | 1.07M | 1.06M |
|
|
|||||
| Common Stock & APIC | 926.92M | 926.78M | 926.53M | 926.23M | 922.58M |
| Retained Earnings | -925.63M | -924.62M | -923.73M | -922.57M | -921.52M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 1.29M | 2.15M | 2.80M | 3.66M | 1.06M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.29M | 2.15M | 2.80M | 3.66M | 1.06M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.29M | 2.15M | 2.80M | 3.66M | 1.06M |
|
|
|||||